Knight Therapeutics Inc. (GUD) Wins Exclusive Poteligeo Distribution in Key LatAm Markets

Knight Therapeutics signed an exclusive agreement with Kyowa Kirin International to seek approvals and commercialize mogamulizumab (Poteligeo) in Brazil, Mexico, Colombia and Argentina.Material DetailsContext by AI AnalystThis is an early-stage expansion move adding a rare-oncology asset to Knight’…